← Leaderboards
Judith A Erlen
University Of Pittsburgh At Pittsburgh
$6,298,458
Attributed
$6,298,458
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $932K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,298,458 · 4
By mechanism
R01$3,626,824 · 1
T32$1,710,878 · 1
P01$683,242 · 1
P30$277,514 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Milos Hauskrecht$3,805,461
- Gilles Clermont$11,470,744
- Brooke S.g. Molina$32,831,004
- Margaret Q Rosenzweig$6,246,798
- Titus K Schleyer$6,483,805
Others in their field
Top investigators on “Chronic Disease”
- Judith S. Currier · University Of California Los Angeles$245,012,139
- Lawrence Corey · Fred Hutchinson Cancer Center$203,445,555
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$201,828,077
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$173,476,538
- John M Lachin · George Washington University$125,907,614
- David M Nathan · Massachusetts Institute Of Technology$120,438,756
Research focus
Chronic DiseaseTechnologyQuality Of LifeCritical IllnessPersonsSeriesTranslationsCommunitiesEducational AspectsTranslatingRandomizedProgramsAdherence (Attribute)Protocols DocumentationPersonal Log /DiaryCaringMediatingHospitalizationImmunologic Assay /TestDesignBehavioral /Social Science Research TagPatient Self-ReportAdultEvent
Grant awards (29)
Technology Research in Chronic and Critical Illness$4,095
T32 · FY2017 · NR · contact PI
Technology Research in Chronic and Critical Illness$133,586
T32 · FY2016 · NR · contact PI
Technology Research in Chronic and Critical Illness$121,241
T32 · FY2015 · NR · contact PI
Technology Research in Chronic and Critical Illness$183,449
T32 · FY2014 · NR · contact PI
Technology Research in Chronic and Critical Illness$224,126
T32 · FY2013 · NR · contact PI
Strategies to improve caregiver mediated medication management of community dwell$128,579
P01 · FY2012 · NR · contact PI
Technology Research in Chronic and Critical Illness$1
T32 · FY2012 · NR · contact PI
Strategies to improve caregiver mediated medication management of community dwell$139,374
P01 · FY2011 · NR · contact PI
Strategies to improve caregiver mediated medication management of community dwell$140,804
P01 · FY2010 · NR · contact PI
Technology: Research in Chronic and Critical Illness$273,026
T32 · FY2009 · NR · contact PI
Strategies to improve caregiver mediated medication management of community dwell$138,106
P01 · FY2009 · NR · contact PI
Strategies to improve caregiver mediated medication management of community dwell$136,379
P01 · FY2008 · NR · contact PI
Technology: Research in Chronic and Critical Illness$119,228
T32 · FY2008 · NR · contact PI
Core--Research Development$48,823
P30 · FY2008 · NR · contact PI
Improving Adherence to Antiretroviral Therapy$522,851
R01 · FY2007 · NR · contact PI
Technology: Research in Chronic and Critical Illness$259,957
T32 · FY2007 · NR · contact PI
Core--Research Development$75,595
P30 · FY2007 · NR · contact PI
Improving Adherence to Antiretroviral Therapy$581,192
R01 · FY2006 · NR · contact PI
Technology: Research in Chronic and Critical Illness$304,537
T32 · FY2006 · NR · contact PI
Core--Research Development$46,276
P30 · FY2006 · NR · contact PI
Improving Adherence to Antiretroviral Therapy$609,895
R01 · FY2005 · NR
Technology: Research in Chronic and Critical Illness$87,632
T32 · FY2005 · NR
Core--Research Development$58,505
P30 · FY2005 · NR
Improving Adherence to Antiretroviral Therapy$553,143
R01 · FY2004 · NR
Core--Research Development$48,315
P30 · FY2004 · NR
Improving Adherence to Antiretroviral Therapy$621,564
R01 · FY2003 · NR
ADHERENCE TO PROTEASE INHIBITORS$64,905
R01 · FY2002 · NR
ADHERENCE TO PROTEASE INHIBITORS$322,853
R01 · FY2001 · NR
ADHERENCE TO PROTEASE INHIBITORS$350,421
R01 · FY2000 · NR